Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02291913 | Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer | completed | Phase 2 | 48 | SCRI Development Innovations, LLCOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT00343109 | Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer | completed | Phase 2 | 38 | University of WashingtonOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT01355393 | Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer | completed | Phase 1 / Phase 2 | 50 | University of WashingtonOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT02152462 | Exergaming Intervention and Breast Cancer Biomarkers in Black Women(POWER) | completed | Phase 2 | 150 | Georgetown UniversityOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT01299038 | Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer | completed | Phase 2 | 20 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03450044 | Immunogenicity and Safety of DCs in Breast Cancer(TEBICA) | completed | Phase 1 / Phase 2 | 15 | Fundación Salud de los AndesOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT01763931 | DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer | completed | Phase 2 | 6 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT00274768 | Capecitabine in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 26 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT01484080 | Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates | completed | Phase 1 / Phase 2 | 140 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT01065441 | Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer | completed | Phase 1 / Phase 2 | 9 | Michael Har-NoyINDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02102490 | A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread(MONARCH 1) | completed | Phase 2 | 132 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 21, 2020 | clinicaltrials |
| NCT02312934 | Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study | completed | Phase 2 | 22 | Vanderbilt University Medical CenterOTHER | 1 | Jan 21, 2020 | clinicaltrials |
| NCT04224922 | Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast Cancer | completed | Phase 2 | 63 | Universitair Ziekenhuis BrusselOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT02455453 | Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography | completed | Phase 2 | 47 | Washington University School of MedicineOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT01118624 | Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer | completed | Phase 2 | 22 | Acrotech Biopharma Inc.INDUSTRY | 4 | Jan 7, 2020 | clinicaltrials |
| NCT00313170 | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg(FINDER II) | completed | Phase 2 | 144 | AstraZenecaINDUSTRY | 8 | Jan 6, 2020 | clinicaltrials |
| NCT00978250 | A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) | completed | Phase 2 | 95 | National Cancer Institute (NCI)NIH | 1 | Dec 27, 2019 | clinicaltrials |
| NCT02541370 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 | completed | Phase 1 / Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00003219 | Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | — | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT00204776 | XELOX for Metastatic Breast Cancer | completed | Phase 2 | 37 | University of Wisconsin, MadisonOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00263588 | Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer | completed | Phase 2 | 242 | Novartis PharmaceuticalsINDUSTRY | 17 | Dec 12, 2019 | clinicaltrials |
| NCT00213980 | Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer | completed | Phase 2 | 68 | University of Wisconsin, MadisonOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT01671319 | Dose Dense TC + Pegfilgrastim Support for Breast Cancer(ddTC) | completed | Phase 2 | 42 | University of Wisconsin, MadisonOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT02697032 | FDHT PET and Bicalutamide in Metastatic Breast Cancer | completed | Phase 2 | 22 | University Medical Center GroningenOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT03072992 | "Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer | completed | Phase 2 | 150 | National Center of Oncology, ArmeniaOTHER | 1 | Nov 27, 2019 | clinicaltrials |
| NCT00093145 | Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer | completed | Phase 2 | 32 | CelgeneINDUSTRY | 1 | Nov 25, 2019 | clinicaltrials |
| NCT00394082 | ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer | completed | Phase 2 | 50 | CelgeneINDUSTRY | 1 | Nov 25, 2019 | clinicaltrials |
| NCT00274456 | Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast Cancer | completed | Phase 2 | 302 | CelgeneINDUSTRY | 1 | Nov 21, 2019 | clinicaltrials |
| NCT01816594 | NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer(NeoPHOEBE) | completed | Phase 2 | 50 | Novartis PharmaceuticalsINDUSTRY | 4 | Nov 14, 2019 | clinicaltrials |
| NCT01783756 | Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis | completed | Phase 1 / Phase 2 | 9 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2019 | clinicaltrials |
| NCT00548184 | Lapatinib and Trastuzumab With or Without Endocrine Therapy | completed | Phase 2 | 65 | Baylor Breast Care CenterOTHER | 1 | Nov 7, 2019 | clinicaltrials |
| NCT00721409 | Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer | completed | Phase 2 | 177 | PfizerINDUSTRY | 12 | Nov 4, 2019 | clinicaltrials |
| NCT00393172 | Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)](WISER) | completed | Phase 2 / Phase 3 | 400 | University of MinnesotaOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT00451555 | Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer | completed | Phase 2 | 156 | Eli Lilly and CompanyINDUSTRY | 5 | Nov 1, 2019 | clinicaltrials |
| NCT02628613 | Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations | completed | Phase 2 | 91 | Fudan UniversityOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT00240071 | Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca. | completed | Phase 2 | 30 | University of Alabama at BirminghamOTHER | 1 | Oct 30, 2019 | clinicaltrials |
| NCT01869764 | Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer | completed | Phase 2 | 57 | Wake Forest University Health SciencesOTHER | 1 | Oct 30, 2019 | clinicaltrials |
| NCT02839668 | The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)(TIVA/TCI-BC) | completed | Phase 2 | 120 | Iuliu Hatieganu University of Medicine and PharmacyOTHER | 1 | Oct 29, 2019 | clinicaltrials |
| NCT02126449 | DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer(DIRECT) | completed | Phase 2 / Phase 3 | 131 | Leiden University Medical CenterOTHER | 1 | Oct 24, 2019 | clinicaltrials |
| NCT00820547 | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients(Beverly1) | completed | Phase 2 | 100 | UNICANCEROTHER | 1 | Oct 22, 2019 | clinicaltrials |
| NCT02616744 | Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors(BONADIUV) | completed | Phase 2 | 171 | Azienda Ospedaliero-Universitaria CareggiOTHER | 1 | Oct 22, 2019 | clinicaltrials |
| NCT00820872 | Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer | completed | Phase 2 | 30 | Alliance for Clinical Trials in OncologyOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT02783794 | BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer | completed | Phase 2 | 36 | Meabco A/SINDUSTRY | 2 | Oct 10, 2019 | clinicaltrials |
| NCT03789019 | BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment | completed | Phase 2 | 29 | Meabco A/SINDUSTRY | 2 | Oct 10, 2019 | clinicaltrials |
| NCT00003612 | Combination Chemotherapy and Trastuzumab in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 92 | Alliance for Clinical Trials in OncologyOTHER | 2 | Oct 8, 2019 | clinicaltrials |
| NCT01100463 | Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome | completed | Phase 1 / Phase 2 | 18 | Nanometics (d.b.a. PHD Biosciences)INDUSTRY | 1 | Oct 8, 2019 | clinicaltrials |
| NCT00186121 | Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women | completed | Phase 2 | 35 | Stanford UniversityOTHER | 1 | Oct 7, 2019 | clinicaltrials |
| NCT03603197 | BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer | completed | Phase 2 | 38 | Meabco A/SINDUSTRY | 1 | Oct 7, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Feb 17, 2020source: clinicaltrials